Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA...
Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA approval decisions between now and April, and the relevant dates. The closest D-Day is for Gilead (GILD -1.1%) on Monday next week, when the FDA will decide on the firm's Quad for HIV treatment, which combines four drugs into a single, once-daily pill.
From other sites
Video at CNBC.com (Mon, 12:56PM)
Video at CNBC.com (Jul 29, 2015)
at CNBC.com (May 22, 2015)
Video at CNBC.com (Feb 3, 2015)
at CNBC.com (Feb 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs